What is it about?
The drug lag for anticancer drugs between Japan and the US reached its lowest level in 2018. Our findings suggest that globalization and changes in domestic policies have had strong impacts on changes in drug lag.
Featured Image
Why is it important?
The drug lag between anticancer drugs in Japan and the US is believed to have disappeared. The long-term trend was unclear.
Perspectives
This is the first study to provide long-term and comprehensive information on the drug lag between Japan and the US, which could be used to elucidate global challenges in the development of pharmaceuticals.
PhD Hideki Maeda
Meiji Yakka Daigaku
Read the Original
This page is a summary of: Trends in oncology drug lags in Japan from 2001 to 2020: A cross‐sectional study, Clinical and Translational Science, October 2023, Wiley,
DOI: 10.1111/cts.13660.
You can read the full text:
Contributors
The following have contributed to this page
